TABLE 3.
Significant associations between antimicrobial resistance and consumption, as well as antimicrobial resistance and timea
| Antimicrobial | Effect | PE | SE | DF | t value | P value |
|---|---|---|---|---|---|---|
| Trimethoprim resistance vs: | ||||||
| Trimethoprim consumption | Intercept | 22.7864 | 2.5613 | 19 | 8.90 | <0.0001 |
| Use | 1.8562 | 1.7348 | 101 | 1.07 | 0.2872 | |
| Time | −1.0350 | 0.1599 | 18 | −6.47 | <0.0001 | |
| Trimethoprim-sulfamethoxazole consumption | Intercept | 23.4825 | 2.8711 | 19 | 8.18 | <0.0001 |
| Use | 1.6784 | 2.6296 | 101 | 0.64 | 0.5248 | |
| Time | −0.9185 | 0.2281 | 18 | −4.03 | 0.0008 | |
| Trimethoprim + trimethoprim-sulfamethoxazole | Intercept | 21.7928 | 3.2112 | 19 | 6.79 | <0.0001 |
| consumption | Use | 1.4929 | 1.3003 | 101 | 1.15 | 0.2536 |
| Time | −0.9414 | 0.1789 | 18 | −5.26 | <0.0001 | |
| Trimethoprim-sulfamethoxazole resistance vs trimethoprim | Intercept | 14.8609 | 3.2751 | 14 | 4.54 | 0.0005 |
| consumption | Use | 4.0385 | 2.2581 | 51 | 1.79 | 0.0796 |
| Time | −0.5120 | 0.1972 | 14 | −2.60 | 0.0211 | |
| Amdinocillin resistance vs pivemecillinam | Intercept | 6.6642 | 0.8741 | 19 | 7.62 | <0.0001 |
| consumption | Use | −2.3751 | 2.0454 | 99 | −1.16 | 0.2484 |
| Time | −0.3489 | 0.1067 | 18 | −3.27 | 0.0042 | |
| Nitrofurantoin resistance vs: | ||||||
| Cephalosporin consumption | Intercept | 1.8621 | 0.5244 | 19 | 3.55 | 0.0021 |
| Use | 0.5351 | 0.2420 | 101 | 2.21 | 0.0293 | |
| Time | −0.1649 | 0.01780 | 18 | −9.26 | <0.0001 | |
| Nitrofurantoin consumption | Intercept | 1.3163 | 0.4149 | 19 | 3.17 | 0.0050 |
| Use | 2.3330 | 0.5706 | 101 | 4.09 | <0.0001 | |
| Time | −0.1470 | 0.01888 | 18 | −7.78 | <0.0001 | |
| Fluoroquinolone resistance vs: | ||||||
| Amoxicillin consumption | Intercept | −0.7831 | 0.9665 | 18 | −0.81 | 0.4284 |
| Use | 1.1040 | 0.3602 | 67 | 3.07 | 0.0031 | |
| Time | 0.1340 | 0.05816 | 17 | 2.30 | 0.0341 | |
| Cephalosporin consumption | Intercept | 0.4062 | 1.1655 | 19 | 0.35 | 0.7312 |
| Use | 0.6954 | 0.5089 | 84 | 1.37 | 0.1754 | |
| Time | 0.1348 | 0.04830 | 18 | 2.79 | 0.0121 | |
| Levofloxacin consumption | Intercept | 1.4633 | 0.3140 | 19 | 4.66 | 0.0002 |
| Use | 2.3937 | 1.4940 | 70 | 1.60 | 0.1136 | |
| Time | 0.1553 | 0.05384 | 18 | 2.88 | 0.0099 | |
| Ampicillin resistance vs: | ||||||
| Fluoroquinolone consumption | Intercept | 26.4905 | 1.4621 | 10 | 18.12 | <0.0001 |
| Use | 6.0910 | 2.0193 | 37 | 3.02 | 0.0046 | |
| Time | −1.0954 | 0.1987 | 9 | −5.51 | 0.0004 | |
| Amoxicillin consumption | Intercept | 27.2247 | 3.0584 | 10 | 8.90 | <0.0001 |
| Use | 0.4518 | 1.1006 | 37 | 0.41 | 0.6838 | |
| Time | −0.6667 | 0.1602 | 9 | −4.16 | 0.0024 | |
| Amoxicillin-clavulanic acid consumption | Intercept | 28.4583 | 1.0262 | 10 | 27.73 | <0.0001 |
| Use | 0.7535 | 1.6045 | 37 | 0.47 | 0.6414 | |
| Time | −0.7592 | 0.2161 | 9 | −3.51 | 0.0066 |
Significant associations between resistance and consumption are highlighted in boldface type. Parameter estimates (PE), standard errors, degrees of freedom (DF), t values, and P values were obtained by fitting a linear mixed model for repeated measures. The fixed-effects estimates shown here represent the estimated means for the random intercept and slope. See the Materials and Methods section for more detailed information.